ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
4.875
-0.475 (-8.88%)
At close: Nov 20, 2024, 4:00 PM
4.850
-0.025 (-0.51%)
Pre-market: Nov 21, 2024, 7:42 AM EST
ImmunityBio Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for ImmunityBio stock have an average target of 17.38, with a low estimate of 4.75 and a high estimate of 30. The average target predicts an increase of 256.51% from the current stock price of 4.88.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ImmunityBio stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | +515.38% | Nov 19, 2024 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | +515.38% | Nov 12, 2024 |
| EF Hutton | EF Hutton | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +515.38% | Oct 23, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $6 → $4.75 | Hold | Maintains | $6 → $4.75 | -2.56% | Aug 19, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $5 → $6 | Hold | Maintains | $5 → $6 | +23.08% | Apr 29, 2024 |
Financial Forecast
Revenue This Year
10.35M
from 622.00K
Increased by 1,563.18%
Revenue Next Year
140.92M
from 10.35M
Increased by 1,262.20%
EPS This Year
-0.84
from -1.15
EPS Next Year
-0.65
from -0.84
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 16.9M | 179.3M | 496.5M |
| Avg | 10.3M | 140.9M | 358.1M |
| Low | 1.2M | 111.3M | 265.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 2,624.6% | 1,633.2% | 252.3% |
| Avg | 1,563.2% | 1,262.2% | 154.1% |
| Low | 87.0% | 976.2% | 88.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.77 | -0.44 | -0.16 |
| Avg | -0.84 | -0.65 | -0.36 |
| Low | -0.97 | -0.86 | -0.61 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.